Postmenopausal hormone therapy: less favourable risk–benefit ratios in healthy Dutch women

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Journal of Internal Medicine

• Publication date

  2000-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1046/j.1365-2796.2000.00714.xPMID 10947893
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Incidence of cancer in the Netherlands.

  2001cited by this paper
• Individualizing therapy to prevent long-term consequences of estrogen deficiency in postmenopausal women.

  1999cited by this paper
• Postmenopausal hormone therapy and risk of cardiovascular disease and hip fracture in a cohort of Swedish women.

  1999cited by this paper
• The new old epidemic of coronary heart disease.

  1999cited by this paper
• Hormone replacement therapy, heart disease, and other considerations.

  1998cited by this paper
• Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.

  1998cited by this paper
• Hip Fracture Prediction in Elderly Men and Women: Validation in the Rotterdam Study

  1998cited by this paper
• Coping with multiple morbidity in a life table.

  1998cited by this paper
• Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer.

  1997cited by this paper
• Postmenopausal hormone therapy and mortality.

  1997cited by this paper
• Postmenopausal hormone therapy and mortality.

  1997cited by this paper
• Patient-specific decisions about hormone replacement therapy in postmenopausal women.

  1997cited by this paper
• The climacteric in The Netherlands: a review of Dutch studies on epidemiology, attitudes and use of hormone replacement therapy.

  1996cited by this paper
• 27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 5. Stratification of patients into high, medium and low risk subgroups for purposes of risk factor management.

  1996cited by this paper
• Hormone replacement therapy in a risk-benefit perspective.

  1996cited by this paper
• Estrogen Replacement Therapy and Fractures in Older Women

  1995cited by this paper
• Estrogen replacement therapy and fractures in older women. Study of Osteoporotic Fractures Research Group.

  1995cited by this paper
• Relative risks and benefits of long‐term estrogen replacement therapy: A decision analysis

  1994cited by this paper
• The influence of occupational activity on the menstrual cycle and fecundability.

  1994cited by this paper
• Myocardial Infarction and Coronary Deaths in the World Health Organization MONICA Project: Registration Procedures, Event Rates, and Case‐Fatality Rates in 38 Populations From 21 Countries in Four Continents

  1994cited by this paper
• Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal Women

  1992cited by this paper
• Determinants of disease and disability in the elderly: The Rotterdam elderly study

  1991cited by this paper
• MYOCARDIAL INFARCTION

  1944cited by this paper

• Gender differences in cardiovascular disease

  2024cites this paper
• Hormone Replacement Therapy and Mortality for Ischaemic Heart Disease, Cerebrovascular Diseases and Breast Cancer in Italy and the U.S.A

  2020cites this paper
• Hormone Replacement Therapy and Mortality for Ischaemic Heart Disease , Cerebrovascular Diseases and Breast Cancer in Italy and the U .

  2019cites this paper
• Hormone Replacement Therapy and Mortality for Ischaemic Heart Disease, Cerebrovascular Diseases and Breast Cancer in Italy and the U.S.A

  2019cites this paper
• Gender differences in cardiovascular disease

  2019cites this paper
• Hormone Replacement Therapy and Mortality for Ischaemic Heart Disease , Cerebrovascular Diseases and Breast Cancer in Italy and the U .

  2018cites this paper
• Hormone replacement therapy and breast cancer risk in Kyushu University Hospital: Supporting the Women's Health Initiative study

  2004cites this paper
• Gender differences in cardiovascular disease : an epidemiologic study of endocrine factors

  2002cites this paper
• Hormone therapy and the cardiovascular system.

  2002cites this paper
• Is there a menopausal medicine? The past the present and the future.

  2002cites this paper
• The effects of a soy rich diet on serum lipids: the Menfis randomized trial.

  2002cites this paper
• Hormone Replacement Therapy and Mortality for Ischaemic Heart Disease, Cerebrovascular Diseases and Breast Cancer in Italy and the U.S.A.

  2002cites this paper
• Therapy and clinical trials.

  2001cites this paper
• The Nurses' Health Study: unresolved issues after 20-years follow-up.

  2001cites this paper
• Effects of genistein and daidzein on arterial tone and blood pressure in rats

  2001cites this paper
• The Queen... is naked!

  2001cites this paper
• Anti-Aging Medicine LiteratureWatch

  2000cites this paper
• Pharmacoepidemiology

  1996cites this paper